PARP Combination Therapies: A New Horizon in Prostate Cancer Care

Gain expert insight on the evolving role of PARP inhibitor therapy including in combination with AR-targeting agents for the treatment of advanced prostate cancer by watching an on-demand webcast of a live symposium downloading the accompanying slidesets and reading a commentary of FAQs from the symposium.

Share

Program Content

Activities

PARPi Combinations
PARP Inhibitor Combination Therapies: A New Horizon in Prostate Cancer Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2022

Expires: February 21, 2023

PARPi Monotherapy
Current Use of PARP Inhibitors in Prostate Cancer: Rationale and Key Monotherapy Data
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2022

Expires: February 21, 2023

Genetic Testing in PCa
Selecting Patients for PARP Inhibitor Therapy: Principles of Genetic Testing
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2022

Expires: February 22, 2023

No activities added yet

Activities

PARPi in PCa: Key Issues
My Thoughts on Key Issues With PARP Inhibitors for Prostate Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 26, 2022

Expires: April 25, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer, Inc.